We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 585

HHS Proposes Disclosure of Drug Prices in TV Advertising, But Fight Over Authority On the Horizon
  • Arent Fox LLP
  • USA
  • October 29 2018

The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or


FDA Warns Against Sales Representative’s “False and Misleading” Oral Statements Regarding Prescription Medicine
  • Drinker Biddle & Reath LLP
  • USA
  • October 25 2018

The U.S. Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) sent an untitled letter to Eisai Inc. on October 11, 2018, based


HHS Secretary Azar Announces DTC Drug Price Transparency Proposal, Foreshadows Additional Regulatory Action to Address Drug Prices
  • Sidley Austin LLP
  • USA
  • October 16 2018

On October 15, 2018, Secretary of Health and Human Services (HHS) Alex Azar delivered remarks at a National Academy of Medicine event in which he


Anti-Tobacco Messaging Could Hit Airwaves and Print Soon, Depending on Court’s Entry of Order
  • Troutman Sanders LLP
  • USA
  • October 6 2017

Expect about a year’s worth of new anti-tobacco messaging on television and in the newspaper as the result of a recent Consent Motion in United States


Coming soon from FDA? Streamlined safety information in prescription drug television ads
  • DLA Piper
  • USA
  • September 7 2017

Most people are by now familiar with prescription drug TV ads that provide lengthy (and often confusing) laundry-list descriptions of


Exaggerated Diagnosis Codes and Inadequate Provider Networks: Allegations of Medicare Advantage Fraud Settled for $32.5 Million
  • Baker & Hostetler LLP
  • USA
  • June 20 2017

The latest settlement involving Medicare Advantage (MA) organizations highlights not only the government’s continuing enforcement focus on Medicare


Sandoz Inc. v. Amgen Inc.
  • Merchant & Gould
  • USA
  • June 16 2017

In a unanimous decision in Sandoz Inc. v. Amgen Inc., the U.S. Supreme Court held that injunctive relief was not available under federal law to


Washington Becomes Third State to Enact Biometric Privacy Law
  • Hunton Andrews Kurth LLP
  • USA
  • June 1 2017

On May 16, 2017, the Governor of the State of Washington, Jay Inslee, signed into law House Bill 1493 (“H.B. 1493”), which sets forth requirements for


A Closer Look at Wisconsin’s Premium Proposal
  • Manatt Phelps & Phillips LLP
  • USA
  • May 22 2017

The State of Wisconsin recently proposed a Medicaid waiver that includes a number of precedent-setting features, including a 48-month time limit on


Canada expands protection of individual rights with new legislation on genetic testing and privacy
  • DLA Piper
  • USA, Canada
  • April 26 2017

Significant legislative changes are on the horizon in the field of genetic testing with Parliament’s recent passage of Bill S-201: An Act to Prohibit